• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲苯胺蓝溶液作为口咽癌诊断辅助手段]

[Toluidine blue solution as a diagnostic aid in oropharyngeal cancer].

作者信息

Gómez Serrano M T, Toranzo Fernández J M, Martínez Bravo J

出版信息

Rev ADM. 1989 Jan-Feb;46(1):29-35.

PMID:2634420
Abstract

In the literature exist investigations made to extensive series of patients, with premalignant oral lesions or suspicious of malignancy, in which it has been employed toluidine blue (TB), to verify the trustiness of this method as a resource for support in clinical diagnosis. The results are favourable whenever is observed the correct realization of the technique that must be preceded by a careful buccal exploration and that both findings be corroborated. This work tries to exemplificate one of the techniques of TB as will as the results obtained in 28 patients, whom, for their characteristics were considered of High Risk. Emphasis is made in relation to the false positive found. Besides, is insisted in the convenience of the routine use of this resource in the odontologic private practice and at institutional level in patients over 50 years old, to whom is necessary to accomplish at a time an adequate patient history and an accurate intraoral examination, that in addition to the use of TB, will make feasible to detect more cases of malignant lesions in early stages.

摘要

在文献中,存在针对大量患有口腔癌前病变或疑似恶性病变患者的研究,其中使用了甲苯胺蓝(TB)来验证该方法作为临床诊断辅助手段的可靠性。只要观察到该技术的正确实施(必须先进行仔细的口腔检查且两项检查结果相互佐证),结果就是令人满意的。这项工作试图举例说明TB技术之一以及在28例因其特征被视为高危患者中获得的结果。重点关注了发现的假阳性情况。此外,强调了在牙科私人诊所和机构层面,对50岁以上患者常规使用该资源的便利性,对于这些患者,有必要同时完成充分的患者病史记录和准确的口腔内检查,除了使用TB之外,这将有助于在早期发现更多恶性病变病例。

相似文献

1
[Toluidine blue solution as a diagnostic aid in oropharyngeal cancer].[甲苯胺蓝溶液作为口咽癌诊断辅助手段]
Rev ADM. 1989 Jan-Feb;46(1):29-35.
2
Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.通过视觉检查、化学发光和甲苯胺蓝鉴定并评估的口腔病变活检分析。
Oral Oncol. 2008 Jun;44(6):538-44. doi: 10.1016/j.oraloncology.2007.08.011. Epub 2007 Nov 8.
3
Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.甲苯胺蓝在口腔癌前病变和鳞状细胞癌中的应用:持续研究及其对临床实践的启示
Head Neck. 2007 Oct;29(10):948-58. doi: 10.1002/hed.20637.
4
The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.甲苯胺蓝在检测口腔癌前病变和恶性病变中的应用。
J Oral Pathol Med. 2011 Apr;40(4):300-4. doi: 10.1111/j.1600-0714.2010.00985.x.
5
[Toluidine blue staining for detection of oral squamous carcinoma].[用于检测口腔鳞状细胞癌的甲苯胺蓝染色]
Ned Tijdschr Tandheelkd. 1990 Oct;97(10):431-2.
6
Increased allelic loss in toluidine blue-positive oral premalignant lesions.甲苯胺蓝阳性口腔癌前病变中等位基因缺失增加。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):45-50. doi: 10.1067/moe.2003.97.
7
Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.ViziLite Plus系统在口腔癌/癌前上皮病变早期检测中作为诊断辅助手段的价值。
J Craniofac Surg. 2012 Mar;23(2):e162-4. doi: 10.1097/SCS.0b013e31824cdbea.
8
[Detection of buccal cavity cancers with toluidine blue (author's transl)].用甲苯胺蓝检测口腔癌(作者译)
Rev Stomatol Chir Maxillofac. 1980;81(6):364-7.
9
[Incidence of esophageal cancer synchronous with upper aerodigestive tract cancers (100 cases): value of vital staining with lugol and toluidine blue].[食管癌与上消化道癌同时发生的发生率(100例):卢戈氏碘液和甲苯胺蓝活体染色的价值]
Gastroenterol Clin Biol. 1985 Jan;9(1):16-22.
10
Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.甲苯胺蓝染色可识别预后不良的高危原发性口腔癌前病变。
Cancer Res. 2005 Sep 1;65(17):8017-21. doi: 10.1158/0008-5472.CAN-04-3153.

引用本文的文献

1
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.对出现临床明显病变的患者进行口腔癌及潜在恶性疾病的诊断测试。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD010276. doi: 10.1002/14651858.CD010276.pub3.
2
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.针对出现临床明显病变的患者进行口腔癌及潜在恶性疾病的诊断测试。
Cochrane Database Syst Rev. 2015 May 29;2015(5):CD010276. doi: 10.1002/14651858.CD010276.pub2.